Open access
Correction: Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy
Medicine
Abstract
[This corrects the article DOI: 10.3389/fphar.2026.1897246.].